ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0110

Implementation and Outcomes of a Continuous Quality Improvement Program in Continuous Renal Replacement Therapy at Tertiary Care Hospitals

Session Information

Category: Acute Kidney Injury

  • 102 AKI: Clinical, Outcomes, and Trials

Authors

  • Mercado Hernández, Yazmin Alejandra, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, CDMX, Mexico
  • Vega, Olynka, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, CDMX, Mexico
  • Galindo, Pablo E., Hospital General de Mexico Dr Eduardo Liceaga, Mexico City, CDMX, Mexico
  • Mendez Morales, Mario Alejandro, Hospital General de Mexico Dr Eduardo Liceaga, Mexico City, CDMX, Mexico
Background

The aim of this study was to compare the degree of goal achievement in quality metrics (QMs) for continuous renal replacement therapy (CRRT) before and after the sequential implementation of a continuous quality improvement program (CQIP) in two university hospitals.

Methods

This ambispective study was divided into three periods: Period 1 (retrospective, 2016–2019), before CQIP implementation in hospital 1; Period 2 (prospective, 2020–2023), after CQIP implementation in hospital 1; Period 3 (prospective, 2024–2025), after initiating a CRRT program in hospital 2 with the CQIP. The CQIP included regional citrate anticoagulation (RCA) and continuing education for staff. Clinical and technical data were collected, QMs calculated, and comparisons made across the periods.

Results

A total of 209, 412, and 377 CRRT sessions were performed in 59, 93, and 89 patients during periods 1, 2, and 3, respectively. RCA was used in 46.5% of sessions in period 2 and 77% in period 3. The median filter lifespan increased from 36.5 h in period 1 to 64 h in period 2, and 81 h in period 3. The proportion of filters lasting >60 h rose from 23% to 54.5%, and 71%, respectively. Sessions with a delivered/prescribed dose ratio >80% increased from 84% to 94%, and those with downtime <10% rose from 65.5% to 74%. Overall, goal achievement improved significantly in period 3 compared to the previous periods.

Conclusion

These improvements in filter performance and QMs reflect the positive impact of CQIP implementation on CRRT delivery and patient care.

Digital Object Identifier (DOI)